Cargando…

Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice

BACKGROUND: Both selenium and non-steroidal anti-inflammatory drug (NSAID) sulindac are effective in cancer prevention, but their effects are affected by several factors including epigenetic alterations and gene expression. The current study was designed to determine the effects of the combination o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Xiuli, Pohl, Nicole, Dong, Huali, Yang, Wancai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566909/ https://www.ncbi.nlm.nih.gov/pubmed/23327547 http://dx.doi.org/10.1186/1756-8722-6-8

Ejemplares similares

OGA heterozygosity suppresses intestinal tumorigenesis in Apc(min/+) mice
por: Yang, Y R, et al.
Publicado: (2014)

Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas
por: Chang, Wen-Chi L, et al.
Publicado: (2018)

Increased Transgenerational Intestinal Tumorigenesis in Offspring of Ionizing Radiation Exposed Parent APC(1638N/+) Mice
por: Suman, Shubhankar, et al.
Publicado: (2017)

ERK activation drives intestinal tumorigenesis in Apc(min/)(+) mice
por: Lee, Sung Hee, et al.
Publicado: (2010)

Intestinal Peyer’s patches prevent tumorigenesis in Apc(Min/+) mice
por: Fujimoto, Kyoko, et al.
Publicado: (2015)

Depletion of p21-activated kinase 1 up-regulates the immune system of APC(∆14/+) mice and inhibits intestinal tumorigenesis
por: Huynh, Nhi, et al.
Publicado: (2017)

Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts
por: Pohl, Nicole M., et al.
Publicado: (2009)

Cancer Stemness in Apc- vs. Apc/KRAS-Driven Intestinal Tumorigenesis
por: Ghazvini, Mehrnaz, et al.
Publicado: (2013)

Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC
por: Faux, Maree C., et al.
Publicado: (2022)

Chemopreventive effect of 4′-hydroxychalcone on intestinal tumorigenesis in Apc(Min) mice
por: Chen, Qing, et al.
Publicado: (2021)

Chemopreventive effect of 4′-hydroxychalcone on intestinal tumorigenesis in Apc(Min) mice
por: Chen, Qing, et al.
Publicado: (2021)

Voluntary exercise inhibits intestinal tumorigenesis in Apc(Min/+ )mice and azoxymethane/dextran sulfate sodium-treated mice
por: Ju, Jihyeung, et al.
Publicado: (2008)

Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APC(Min/+) mice
por: Li, Ye, et al.
Publicado: (2016)

Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc(Min/+) mice
por: He, Zhengxiang, et al.
Publicado: (2017)

Sulindac, 3,3’-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis
por: Femia, Angelo Pietro, et al.
Publicado: (2015)

Antrodia Camphorata Supplement in the Early Life Inhibits Intestinal Tumorigenesis Later in Young Adult APC1638N Mice
por: Lin, Ting-Chun, et al.
Publicado: (2022)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Deficiency of the LIM-Only Protein FHL2 Reduces Intestinal Tumorigenesis in Apc Mutant Mice
por: Labalette, Charlotte, et al.
Publicado: (2010)

The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in Apc(Min )mice
por: Jedlicka, Paul, et al.
Publicado: (2009)

Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells
por: JAKUBOWSKA-MUĆKA, ANNA, et al.
Publicado: (2012)

Dietary Uridine Decreases Tumorigenesis in the Apc(Min/+) Model of Intestinal Cancer
por: Field, Martha S, et al.
Publicado: (2018)

Spontaneous Intestinal Tumorigenesis in Apc (/Min+) Mice Requires Altered T Cell Development with IL-17A
por: Chae, Wook-Jin, et al.
Publicado: (2015)

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats
por: Tinsley, Heather N., et al.
Publicado: (2023)

P-Selectin-Mediated Adhesion between Platelets and Tumor Cells Promotes Intestinal Tumorigenesis in Apc(Min/+) Mice
por: Qi, Cuiling, et al.
Publicado: (2015)

Maslinic Acid-Enriched Diet Decreases Intestinal Tumorigenesis in Apc(Min/+) Mice through Transcriptomic and Metabolomic Reprogramming
por: Sánchez-Tena, Susana, et al.
Publicado: (2013)

Reduction in the resident intestinal myelomonocytic cell population occurs during Apc(Min/+) mouse intestinal tumorigenesis
por: Faluyi, Olusola O., et al.
Publicado: (2021)

Morphology dynamics in intestinal crypt during postnatal development affect age-dependent susceptibility to radiation-induced intestinal tumorigenesis in Apc(Min/+) mice: possible mechanisms of radiation tumorigenesis
por: Sasatani, Megumi, et al.
Publicado: (2022)

Vitamin D receptor absence does not enhance intestinal tumorigenesis in Apc(Pirc/+)rats
por: Irving, Amy A., et al.
Publicado: (2022)

Epigenetic effects of high-fat diet on intestinal tumorigenesis in C57BL/6J-Apc(Min/+) mice
por: Qu, Dan C., et al.
Publicado: (2023)

Sulindac metabolites inhibit epidermal growth factor receptor activation and expression
por: Pangburn, Heather A, et al.
Publicado: (2005)

Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21
por: Zhou, Xue, et al.
Publicado: (2015)

Genetic Mechanisms in Apc-Mediated Mammary Tumorigenesis
por: Kuraguchi, Mari, et al.
Publicado: (2009)

Synergistic inhibition of the APC/C by the removal of APC15 in HCT116 cells lacking UBE2C
por: Garvanska, Dimitriya H., et al.
Publicado: (2016)

Palmatine from Mahonia bealei attenuates gut tumorigenesis in Apc(Min)(/)(+) mice via inhibition of inflammatory cytokines
por: MA, WEI-KUN, et al.
Publicado: (2016)

A Targeted Constitutive Mutation in the Apc Tumor Suppressor Gene Underlies Mammary But Not Intestinal Tumorigenesis
por: Gaspar, Claudia, et al.
Publicado: (2009)

Exercise effects on polyp burden and immune markers in the Apc(Min)(/+) mouse model of intestinal tumorigenesis
por: McCLELLAN, JAMIE L., et al.
Publicado: (2014)

β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesis
por: Cai, Jing, et al.
Publicado: (2015)

Suppressive effects of the NADPH oxidase inhibitor apocynin on intestinal tumorigenesis in obese KK‐A (y) and Apc mutant Min mice
por: Komiya, Masami, et al.
Publicado: (2015)

Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling
por: DU, JUN, et al.
Publicado: (2014)

Theracurmin inhibits intestinal polyp development in Apc‐mutant mice by inhibiting inflammation‐related factors
por: Adachi, Saeko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8o1prml6hfb78cmvbr3es5sjm3